1. Expanded access programmes: patient interests versus clinical trial integrity. Issue 1 (January 2015) Authors: Lorigan, Paul; Ascierto, Paolo A; Dummer, Reinhard; Eggermont, Alexander M; Flaherty, Keith T; Garbe, Claus; Gogas, Helen; Hauschild, Axel; Kefford, Richard F; Kirkwood, John M; Larkin, James; Long, Georgina V; Maio, Michele; McArthur, Grant A; Ribas, Antoni; Robert, Caroline; Schadendorf, Dirk; ... Journal: Lancet oncology Issue: Volume 16:Issue 1(2015:Jan.) Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Expanded access programmes: patient interests versus clinical trial integrity. Issue 1 (January 2015) Authors: Lorigan, Paul; Ascierto, Paolo A; Dummer, Reinhard; Eggermont, Alexander M; Flaherty, Keith T; Garbe, Claus; Gogas, Helen; Hauschild, Axel; Kefford, Richard F; Kirkwood, John M; Larkin, James; Long, Georgina V; Maio, Michele; McArthur, Grant A; Ribas, Antoni; Robert, Caroline; Schadendorf, Dirk; ... Journal: Lancet oncology Issue: Volume 16:Issue 1(2015:Jan.) Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents. Issue 2 (11th August 2006) Authors: Goldstein, Alisa M; Chan, May; Harland, Mark; Hayward, Nicholas K; Demenais, Florence; Timothy Bishop, D; Azizi, Esther; Bergman, Wilma; Bianchi-Scarra, Giovanna; Bruno, William; Calista, Donato; Cannon Albright, Lisa A; Chaudru, Valerie; Chompret, Agnes; Cuellar, Francisco; Elder, David E; Ghior... Other Names: group-author.; group-author. Journal: Journal of medical genetics Issue: Volume 44:Issue 2(2007) Page Start: 99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Immune checkpoint inhibitors in melanoma. (August 2015) Authors: Cooper, Adam J; Carlino, Matteo S; Kefford, Richard F Journal: Melanoma management Issue: Volume 2:Number 3(2015) Page Start: 267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Melanoma risk for CDKN2A mutation carriers who are relatives of population-based case carriers in Australia and the UK. Issue 4 (15th February 2011) Authors: Cust, Anne E; Harland, Mark; Makalic, Enes; Schmidt, Daniel; Dowty, James G; Aitken, Joanne F; Agha-Hamilton, Chantelle; Armstrong, Bruce K; Barrett, Jenny H; Chan, May; Chang, Yu-Mei; Gascoyne, Joanne; Giles, Graham G; Holland, Elizabeth A; Kefford, Richard F; Kukalizch, Kairen; Lowery, Johanna;... Journal: Journal of medical genetics Issue: Volume 48:Issue 4(2011) Page Start: 266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB–C, BRAFV600 mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial. Issue 7 (July 2019) Authors: Long, Georgina V; Saw, Robyn P M; Lo, Serigne; Nieweg, Omgo E; Shannon, Kerwin F; Gonzalez, Maria; Guminski, Alexander; Lee, Jenny H; Lee, Hansol; Ferguson, Peter M; Rawson, Robert V; Wilmott, James S; Thompson, John F; Kefford, Richard F; Ch'ng, Sydney; Stretch, Jonathan R; Emmett, Louise; Kapoo... Journal: Lancet oncology Issue: Volume 20:Issue 7(2019) Page Start: 961 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗